Renaissance Capital logo

BioNTech Priced, Nasdaq: BNTX

German biotech developing individualized immunotherapies for cancer.

Industry: Health Care

Latest Trade: $17.64 0.00 (0.0%)

First Day Return: -5.1%

Return from IPO: +17.6%

Industry: Health Care

BioNTech was founded in 2008 on the understanding that every cancer patient’s tumor is unique and that in order to effectively address this challenge, we must create individualized treatments for each patient. To realize this vision, we combine decades of groundbreaking research in immunology, cutting-edge therapeutic platforms and a suite of patient profiling and bioinformatic tools to develop individualized immunotherapies for cancer as well as other diseases. We leverage powerful new therapeutic mechanisms and exploit a diverse array of biological targets to harness the power of each patient’s immune system to address the unique molecular signature of each patient’s underlying disease. We believe we are uniquely positioned to develop and commercialize the next generation of immunotherapies with the potential to significantly improve clinical outcomes for patients and usher in a new era of individualized medicine. The interconnected dimensions of cancer heterogeneity on which we focus are illustrated below. The interaction between cancer and the immune system is shaped by various host, tumor and environmental factors. The complex interplay of these sources of interpatient heterogeneity both affects the course of disease and determines the most appropriate choice of treatment.
more less
IPO News for BioNTech
more
IPO Data
IPO File Date 09/09/2019
Offer Price $15.00
Price Range $15.00 - $16.00
Offer Shares (mm) 10.0
Deal Size ($mm) $150
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 10/09/2019
Offer Price $15.00
Price Range $15.00 - $16.00
Offer Shares (mm) 10.0
Deal Size ($mm) $150
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
Underwriters
more
Company Data
Headquarters Mainz, Germany
Founded 2008
Employees 1,179
Website www.biontech.de